Goldman Sachs Group Inc Seagen Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 14, 2024	BUY	$191.51 - $216.16 $67.8 Million - $76.5 Million	354,015 New	354,015 $75.1 Million
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $5.42 Million - $6.12 Million	-28,294 Reduced 7.4%	354,015 $75.1 Million
Q2 2023 May 14, 2024	BUY	$187.64 - $206.25 $16.5 Million - $18.2 Million	88,186 Added 29.98%	382,309 $73.6 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $16.5 Million - $18.2 Million	88,186 Added 29.98%	382,309 $73.6 Million
Q1 2023 May 14, 2024	SELL	$127.59 - $203.08 $81.4 Million - $130 Million	-638,088 Reduced 68.45%	294,123 $59.6 Million
Q1 2023 May 11, 2023	SELL	$127.59 - $203.08 $81.4 Million - $130 Million	-638,088 Reduced 68.45%	294,123 $59.6 Million
Q4 2022 May 14, 2024	BUY	$117.37 - $139.17 $4.19 Million - $4.97 Million	35,728 Added 3.99%	932,211 $120 Million
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $4.19 Million - $4.97 Million	35,728 Added 3.99%	932,211 $120 Million
Q3 2022 May 14, 2024	SELL	$135.27 - $180.11 $4.46 Million - $5.94 Million	-32,962 Reduced 3.55%	896,483 $123 Million
Q3 2022 Nov 10, 2022	SELL	$135.27 - $180.11 $4.46 Million - $5.94 Million	-32,962 Reduced 3.55%	896,483 $123 Million
Q2 2022 May 14, 2024	BUY	$108.81 - $179.33 $101 Million - $167 Million	929,445 New	929,445 $164 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $13.2 Million - $21.8 Million	-121,760 Reduced 11.58%	929,445 $164 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $7.53 Million - $9.94 Million	62,968 Added 6.37%	1,051,205 $151 Million
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $34.4 Million - $46.1 Million	-241,630 Reduced 19.65%	988,237 $153 Million
Q3 2021 Nov 10, 2021	BUY	$142.45 - $169.82 $175 Million - $209 Million	1,229,867 New	1,229,867 $209 Million

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account